QQQ   282.33 (+0.66%)
AAPL   116.44 (+1.21%)
MSFT   212.95 (+1.37%)
FB   283.21 (+2.20%)
GOOGL   1,599.47 (+0.96%)
AMZN   3,290.00 (+2.59%)
TSLA   423.76 (+0.83%)
NVDA   535.27 (+1.83%)
BABA   317.14 (+3.35%)
CGC   18.66 (+0.70%)
GE   7.10 (-3.79%)
MU   51.96 (-0.35%)
AMD   79.55 (-3.26%)
T   26.92 (-1.68%)
F   7.92 (-1.37%)
ACB   4.00 (-9.09%)
GILD   60.00 (+0.07%)
NFLX   488.10 (-0.03%)
NIO   28.44 (+9.34%)
BA   155.24 (-3.48%)
DIS   123.31 (-0.60%)
QQQ   282.33 (+0.66%)
AAPL   116.44 (+1.21%)
MSFT   212.95 (+1.37%)
FB   283.21 (+2.20%)
GOOGL   1,599.47 (+0.96%)
AMZN   3,290.00 (+2.59%)
TSLA   423.76 (+0.83%)
NVDA   535.27 (+1.83%)
BABA   317.14 (+3.35%)
CGC   18.66 (+0.70%)
GE   7.10 (-3.79%)
MU   51.96 (-0.35%)
AMD   79.55 (-3.26%)
T   26.92 (-1.68%)
F   7.92 (-1.37%)
ACB   4.00 (-9.09%)
GILD   60.00 (+0.07%)
NFLX   488.10 (-0.03%)
NIO   28.44 (+9.34%)
BA   155.24 (-3.48%)
DIS   123.31 (-0.60%)
QQQ   282.33 (+0.66%)
AAPL   116.44 (+1.21%)
MSFT   212.95 (+1.37%)
FB   283.21 (+2.20%)
GOOGL   1,599.47 (+0.96%)
AMZN   3,290.00 (+2.59%)
TSLA   423.76 (+0.83%)
NVDA   535.27 (+1.83%)
BABA   317.14 (+3.35%)
CGC   18.66 (+0.70%)
GE   7.10 (-3.79%)
MU   51.96 (-0.35%)
AMD   79.55 (-3.26%)
T   26.92 (-1.68%)
F   7.92 (-1.37%)
ACB   4.00 (-9.09%)
GILD   60.00 (+0.07%)
NFLX   488.10 (-0.03%)
NIO   28.44 (+9.34%)
BA   155.24 (-3.48%)
DIS   123.31 (-0.60%)
QQQ   282.33 (+0.66%)
AAPL   116.44 (+1.21%)
MSFT   212.95 (+1.37%)
FB   283.21 (+2.20%)
GOOGL   1,599.47 (+0.96%)
AMZN   3,290.00 (+2.59%)
TSLA   423.76 (+0.83%)
NVDA   535.27 (+1.83%)
BABA   317.14 (+3.35%)
CGC   18.66 (+0.70%)
GE   7.10 (-3.79%)
MU   51.96 (-0.35%)
AMD   79.55 (-3.26%)
T   26.92 (-1.68%)
F   7.92 (-1.37%)
ACB   4.00 (-9.09%)
GILD   60.00 (+0.07%)
NFLX   488.10 (-0.03%)
NIO   28.44 (+9.34%)
BA   155.24 (-3.48%)
DIS   123.31 (-0.60%)
Log in
LON:RENX

Renalytix Ai Share Forecast, Price & News

GBX 465
+5.00 (+1.09 %)
(As of 10/27/2020 05:19 PM ET)
Add
Compare
Today's Range
451.50
Now: GBX 465
478
50-Day Range
415
MA: GBX 472.97
550
52-Week Range
167.65
Now: GBX 465
660
Volume63,577 shs
Average Volume76,807 shs
Market Capitalization£334.94 million
P/E Ratio8.76
Dividend YieldN/A
BetaN/A
Renalytix AI plc develops artificial intelligence (AI) enabled clinical decision support solutions for kidney disease. It is developing KidneyIntelX, an AI-enabled, clinical-laboratory based solution that supports physician decision making by improving identification, prediction, and risk stratification of patients with kidney disease. The company is based in Cardiff, the United Kingdom. Renalytix AI plc (AIM:RENX) operates independently of EKF Diagnostics Holdings plc as of November 2, 2018.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.83 out of 5 stars

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
PhoneN/A
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£105,000.00
Cash FlowGBX 31.70 per share
Book ValueGBX 31.30 per share

Profitability

Miscellaneous

Market Cap£334.94 million
Next Earnings Date10/27/2020 (Estimated)
OptionableNot Optionable
GBX 465
+5.00 (+1.09 %)
(As of 10/27/2020 05:19 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RENX News and Ratings via Email

Sign-up to receive the latest news and ratings for RENX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Renalytix Ai (LON:RENX) Frequently Asked Questions

How has Renalytix Ai's stock been impacted by COVID-19?

Renalytix Ai's stock was trading at GBX 275 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, RENX shares have increased by 69.1% and is now trading at GBX 465.
View which stocks have been most impacted by COVID-19
.

When is Renalytix Ai's next earnings date?

Renalytix Ai is scheduled to release its next quarterly earnings announcement on Tuesday, October 27th 2020.
View our earnings forecast for Renalytix Ai
.

Who are some of Renalytix Ai's key competitors?

What other stocks do shareholders of Renalytix Ai own?

Who are Renalytix Ai's key executives?

Renalytix Ai's management team includes the following people:
  • Mr. James R. McCullough, CEO & Director (Age 51)
  • Mr. O. James Sterling III, Chief Financial Officer
  • Dr. Sally Bowden, Chief Operating Officer
  • Fergus Fleming, CTO & Director
  • Salim Hamir, Company Sec.

What is Renalytix Ai's stock symbol?

Renalytix Ai trades on the London Stock Exchange (LON) under the ticker symbol "RENX."

How do I buy shares of Renalytix Ai?

Shares of RENX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Renalytix Ai's stock price today?

One share of RENX stock can currently be purchased for approximately GBX 465.

How big of a company is Renalytix Ai?

Renalytix Ai has a market capitalization of £334.94 million and generates £105,000.00 in revenue each year.

What is Renalytix Ai's official website?

The official website for Renalytix Ai is www.renalytixai.com.

This page was last updated on 10/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.